Table 7 Significant associations between plasma membrane immunoexpression of the proteins analyzed and clinicopathological data
| Â | n | Positive (%) | p |
|---|---|---|---|
MCT4 | Â | ||
 Parametrial invasion |  |  | 0.002 |
 Absent | 19 | 12 (66.7) |  |
 Present | 26 | 28 (100.0) |  |
 HPV18 infection |  |  | 0.003 |
 Negative | 143 | 119 (83.2) |  |
 Positive | 39 | 39 (100.0) |  |
CD147 | Â | ||
 Distant metastasis |  |  | 0.044 |
 Absent | 95 | 3 (3.2) |  |
 Present | 17 | 3 (17.6) |  |
GLUT1 | Â | ||
 Distant metastasis |  |  | 0.021 |
 Absent | 96 | 41 (42.7) |  |
 Present | 18 | 13 (72.2) |  |
 CAIX |  |  |  |
 Tumor size |  |  | 0.036 |
  < 4 cm | 25 | 24 (96.0) |  |
  > 4 cm | 8 | 5 (62.5) |  |
HPV18 infection | Â | Â | 0.004 |
 Negative | 136 | 106 (77.9) |  |
 Positive | 39 | 38 (97.4) |  |
VEGFR-1 | Â | Â | Â |
 Local metastasis |  |  | 0.027 |
 Absent | 51 | 8 (15.7) |  |
 Present | 20 | 8 (40.0) |  |
 Lymphnode metastasis |  |  | 0.030 |
 Absent | 49 | 9 (18.4) |  |
 Present | 9 | 5 (55.6) |  |